In addition to the known involvement of signaling pathways such as PI3K/AKT/PTEN, the TP53 pathway or the RB1 pathway in glioma growth, the importance of other signaling pathways in this regard is increasingly being explored. This evidence concerns the gene AKT1 and central nervous system cancer.